Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MoneyMouthon Aug 04, 2021 3:49pm
78 Views
Post# 33649601

RE:RE:RE:RE:RE:RE:RE:RE:Sernova is next.

RE:RE:RE:RE:RE:RE:RE:RE:Sernova is next.Bio, I know what you guys have been complaining about, but complaining is not the same thing as offering a solution. Will seeing the AGM voting numbers suddenly fix all of the problems? Who cares what the numbers were, the fact is that the votes passed and knowing if it was close or not will not change the outcome, and will not change your sentiment either. 

So the main other complaint you guys have is with Ray Matthews. Well, what would you have sernova do? Fire him and pay him a nice little severance package? Then post an ad for an IR manager on indeed? I mean really, what is a realistic solution to the Ray Matthews problem and do you think this should be a top priority of the company?

I can see why you would believe there is a lack of transparancy. We as investors are left in the dark with what is truly happening at the company on a week to week basis. However, I'm choosing not to jump to conclusions because there really isn't a reason to.

But ultimately, I don't think the problem is so much in a lack of transparancy, but rather a lack in patience. The problem is that we don't have timelines on anything. We don't have a estimated date to complete enrollment and we won't get one because they clearly have been unable to accurately estimate it anyway. We don't know when we'll get regulatory approval for the thyroid program in canada and the united states. We don't know when the next update on T1D trial will be. We don't know when some of these collaborations will convert into deals. We don't know when some more strategic hires will be made. We don't know how long we have to wait and that makes people extremely impatient.  

So what can Sernova do about it? Give us an inaccurate estimate and just upset us further when they don't meet the deadline? I don't know, to me it seems like you guys will never be satisfied so why bother trying to pander to you anyway? 
<< Previous
Bullboard Posts
Next >>